Taxanes and their derivatives are a class of anticancer agents derived from the yew tree, particularly from *Taxus brevifolia*. These natural products have been extensively studied for their potent antitumor activity. Taxanes function primarily by interfering with microtubule dynamics during cell division, leading to mitotic arrest and ultimately apoptosis in cancer cells. The most well-known taxane is paclitaxel (Taxol), which has been widely used in the treatment of various cancers including ovarian, breast, and lung cancer. Its mechanism of action involves promoting the stabilization of microtubules, thereby inhibiting their depolymerization and disrupting mitosis. In addition to paclitaxel, numerous taxane derivatives have been developed to enhance efficacy, reduce side effects, or target specific types of cancer. For instance, docetaxel (Taxotere) is a semisynthetic analog that shares similar mechanisms but shows enhanced activity in many tumor types. Other derivatives include nanoparticle formulations and prodrugs designed for targeted drug delivery. The development of taxanes and their derivatives represents a significant advancement in chemotherapy, offering promising therapeutic options for patients with advanced or metastatic cancers.